Product Information

RIZATRIPTAN 5 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.5163 per EA under NDC 68462046599. Its NADAC has been published 619 times since Nov 28, 2013.

FDA first approved this application on Dec 31, 2012.

RIZATRIPTAN 5 MG TABLET

rizatriptan benzoate
$0.5163per EA

Strength

5 mg/1

NDC

68462046599

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/17/2025

Active Ingredients

RIZATRIPTAN BENZOATE

Approval Type

Generic (ANDA)

FDA Application

ANDA201967

FDA Approved

12/31/2012

On Market Since

12/31/2012

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for RIZATRIPTAN 5 MG TABLET has been published 619 times since Nov 28, 2013, and over the history we have for it it has declined 66.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5163 per EA
All-time high$1.9320 (Feb 12, 2014)
All-time low$0.3203 (Jul 17, 2024)
52-week high$0.5163
52-week low$0.4709
Median price$0.8346
Average price$0.8563
Largest weekly change+74.4% (Aug 21, 2024)
Weeks tracked619
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

+9.6%

3Y

+20.0%

5Y

-11.8%

All

-66.4%

Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RIZATRIPTAN 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.5163 per EA (NDC 68462046599), effective Oct 1, 2025.

How has the price of RIZATRIPTAN 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG TABLET has declined 66.4%. It has been tracked across 619 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG TABLET?

Since Nov 28, 2013, the NADAC for RIZATRIPTAN 5 MG TABLET has ranged from a low of $0.3203 (Jul 17, 2024) to a high of $1.9320 (Feb 12, 2014), with a median of $0.8346 per EA.

Are there cheaper alternatives to RIZATRIPTAN 5 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 5 MG ODT, is $0.5150 per EA — about 0% below RIZATRIPTAN 5 MG TABLET.

Who manufactures RIZATRIPTAN 5 MG TABLET?

RIZATRIPTAN 5 MG TABLET (NDC 68462046599) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.